Abstract
In today' s competitive environment, meeting planners in the life sciences
industries are increasingly required to take on greater responsibilities. No
longer relegated to marketing support personnel, meeting planners now play a
strategic role. To bolster this transition, most companies employ centralized
structures for their meeting planning departments. More than ever before,
meeting planners interact with and serve an entire organization.
Becoming a strategic function provides key advantages for meeting management,
but the change also brings new challenges on top of complex compliance-related
issues. By and large, regulatory pressures have dramatically altered
companies' meeting management practices - from selecting meeting sites, to
tracking physician spending, and attracting doctors to attend.
This study culminates a yearlong collaboration between Cutting Edge
Information, Medical Meetings magazine and the Center for Business
Intelligence. The report reveals critical trends across the pharmaceutical,
biotech, and medical device industries. Use the report' s hard-to-find
benchmarking data and in-depth analysis to take meeting management to the
next level:
- Overcome compliance-related roadblocks
- Coordinate global compliance
- Balance internal and external customer demands
- Boost meeting attendance and participation
- Forge successful relationships with vendors
Report Statistics
- Pages :138
- Metrics :250+
- Charts and Diagrams :106
Companies Included in Report
- Abbott Laboratories
- Amgen
- BARD Urological Division
- Biogen Idec
- Bristol-Myers Squibb
- Eli Lilly
- EMD Serono
- Holland & Knight
- Hospira
- Human Genome Sciences
- Johnson & Johnson
- Medtronic
- Merck
- Merck Serono
- Pioneer Surgical Technology
- Roche
- Schering-Plough
- Stiefel Labs
- Stryker Spine
- Takeda
- Wyeth
| 
View Cart
